Avantor

Today’s complex manufacturing processes require innovative approaches. With expertise in data analytics and emerging technologies, our Scientific Advisory Board members, like Stacy Springs, Ph.D., provide strategic guidance to help our customers efficiently and safely bring innovations to market.

Discover the advancements pushing the boundaries of chromatography in downstream processing. Jungmin Oh, our Manager of New Product Development, explores the challenges, innovations, and future of biopharma technology in this 'The Medicine Maker' article. https://lnkd.in/gZkXmRjG #BioPharma #Pharma #Chromatography

South Korea's #biopharmaceutical sector is seen thriving post the 2008 crisis, bolstered by major investments. Explore the insights from Narayana Rao R, VP and GM, Asia Middle East & Africa at Avantor, in BioProcess International’s eBook on regional growth, government backing, and industry strategies https://lnkd.in/d-Z6PG3V #AvantorSetsScienceInMotion

Scaling up the production of complex biologics presents two major challenges: managing yield and quality, and addressing impurities not encountered in earlier studies. At ASGCT 2024, our Senior Director, Research and Development, Mohan C Vemuri, will cover these issues, including an essential seminar on controlling variability in gene therapy manufacturing processes. American Society of Gene & Cell Therapy #ASGCT2024

How do you plan early for commercialization, yet remain flexible in your clinical trials? Follow these tips to avoid additional testing, verify the production process, and document sterility and performance. For a holistic scale-up approach, read this article in the European Pharmaceutical Manufacturer magazine featuring our SVP, Research and Development, Bioscience Production, Nandu Deorkar, and our VP, Operations, Clinical Services, George Marquez, MBA, LSSBB. https://lnkd.in/ghmPUDzi

As the pipeline for complex biologics like cell and gene therapies continues to grow, so do manufacturing challenges in producing larger volumes. Next week at the American Society of Gene & Cell Therapy Annual Meeting (#ASGCT2024) in Baltimore, we will highlight our biopharma solutions at booth #1214 in room 314-317. #CGT

Meet Nancy Ling, MBA, the Americas lead for our Pan Asian Middle East Associate Centric Team (PAME ACT) and Senior Director, Global Strategic Sourcing. Nancy emphasizes that “embracing diversity allows everyone to thrive and contribute their best, creating a vibrant and inclusive workplace. At Avantor, the Asian American Pacific Islander (AAPI) community’s identity is celebrated so we can proudly be ourselves.” This AAPI Heritage Month, our PAME ACT is hosting events honoring the contributions of the AAPI community and celebrating its diverse members. #AAPI #Diversity #Inclusion #AAPIHeritageMonth 

To continue enabling our customers to overcome obstacles and realize opportunities, our R&D teams collaborate with members of our Scientific Advisory Board like Erik Sorensen, Ph.D. He emphasizes that applying flexibility and creativity to chemical processes can spark innovation.  https://lnkd.in/gQ3Ebeux

For monoclonal antibody (mAb) manufacturers, transitioning from research to commercialization is a complex process. Learn about three important steps to avoid costly, late-stage process changes from our team of scale-up experts.  #mAbs

For World Safety Day, we congratulate our Sidney, British Columbia manufacturing colleagues for recently surpassing 3,600 days since the last lost-time injury and approaching 2,500 days since the last recordable injury. At Avantor, we are dedicated to ensuring a safe and secure work environment for all. #WorldSafetyDay #SafetyEveryday